Hi Ben,
It tipped RGS, does not provide a target.
Given its record with BLT and a biotech company in US (Organovo), it probably aiming for triple digits return.
Comparing to Mesoblast, RGS is an interesting company.
Short term holders/traders might look for quick monies on this.
Long term, $1 or more!!